[Skip to Content]
Public Health

Coronavirus Antibody Tests—What They Tell Us

JAMA
Video 5 min 43 sec

As antibody tests for COVID-19 hit the market, “serology” has become a buzzword. Serologic testing can’t yet tell if individuals are immune to the SARS-CoV-2 virus. But population testing, by quantifying the number of people who have had an antibody response to infection, can help determine whether to maintain or relax strict public health measures on the way toward protective herd immunity. Watch this video to learn more.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. The Promise and Peril of Antibody Testing for COVID-19

  2. From Mitigation to Containment of the COVID-19 Pandemic

  3. Interpreting Diagnostic Tests for SARS-CoV-2

  4. Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level

See More

Related Multimedia

  1. Sweden and COVID-19

  2. Can We Count on Herd Immunity to Control COVID-19?

See More About

Public Health Pathology and Laboratory Medicine Population Health Coronavirus (COVID-19) Infectious Diseases
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue